查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1659393

全球疫苗注射装置市场

Vaccine Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球疫苗注射装置市场规模将达到 66 亿美元

2024 年全球疫苗输送设备市场规模估计为 51 亿美元，预计到 2030 年将达到 66 亿美元，2024-2030 年分析期间的复合年增长率为 4.4%。注射器是报告中分析的细分市场之一，预计其复合年增长率为 4.4%，到分析期结束时其价值将达到 53 亿美元。在分析期内，喷射器部分的复合年增长率预计为 4.8%。

美国市场预计将达到 14 亿美元，中国市场复合年增长率将达到 7.5%

预计 2024 年美国疫苗输送设备市场规模将达 14 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 14 亿美元，2024-2030 年分析期间的复合年增长率为 7.5%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 1.2% 和 5.0%。在欧洲，德国的复合年增长率预计为 2.1%。

全球疫苗注射设备市场-主要趋势与驱动因素摘要

什么是疫苗输送装置？

疫苗注射装置是专门用于安全、有效和准确地註射疫苗的工具或技术。这些设备包括注射器、无针注射器、微针贴片、滴鼻剂、皮内注射器、口服给药装置等。它们用于运送各种类型的疫苗，包括灭活疫苗、减毒疫苗、mRNA疫苗、次单位疫苗和病毒载体疫苗，确保疫苗到达适当的组织以获得最佳免疫反应。这些设备不仅提高了疫苗接种的效率和准确性，而且还提高了患者的依从性，降低了针刺伤的风险并最大限度地减少了浪费。

疫苗输送装置的重要性在于它们能够透过确保安全有效的疫苗接种来支持成功的疫苗接种计划。有效的疫苗接种对于实现高疫苗接种覆盖率至关重要，特别是在大规模疫苗宣传活动和旨在控制感染疾病的公共卫生工作中。自动失效注射器等装置有助于防止重复使用并降低感染风险，而无针注射器可以提高针头恐惧症患者对疫苗的接受度。随着全球疫苗接种需求的增长，特别是针对流行病、常规免疫和应对新兴感染疾病的需求，疫苗接种装置已成为支持及时有效的免疫接种工作的医疗保健基础设施的重要组成部分。

科技进步如何影响疫苗输送装置市场？

科技进步极大地改善了疫苗注射装置的设计、安全性和效率，促进了世界各地免疫计画的创新。一项重大进展是微针贴片的引入，它提供了一种无痛、微创的皮内注射疫苗的方法。微针贴片可以涂覆或装载疫苗并自行使用，这使其成为大规模疫苗宣传活动和偏远、资源匮乏环境的理想选择。这些贴片不需要冷藏，减少了低温运输物流并促进了更广泛地获得疫苗，特别是在开发中国家。

另一项重大进展是无针注射器的发展。注射器利用高压将疫苗通过皮肤输送，无需针头。这些装置降低了针刺伤的风险，提高了患者的依从性，并最大限度地减少了生物危害废弃物。无针注射器用于注射流感、麻疹和肝炎等疫苗，并且正在适应新冠和结核病等新兴疫苗。无针系统、自动开闭注射器等技术创新提高了疫苗接种的安全性。这些注射器设计为一次使用后自动锁定，防止重复使用并降低交叉污染的风险，使其成为安全疫苗接种所必需的，特别是在大规模宣传活动中。

融入数位技术的智慧配送设备的兴起也正在改变市场。智慧型穿戴式註射器可以监测剂量准确性、追踪管理并收集疫苗接种覆盖率的即时资料，帮助医疗保健提供者改善免疫计划和疫苗追踪。此外，鼻内给药系统的进步扩大了非侵入性疫苗给药的选择，使得流感疫苗等疫苗的给药变得简单有效。这些创新不仅提高了疫苗注射装置的性能和安全性，也符合更容易获得、更易于使用和永续的免疫解决方案的全球目标。

疫苗输送装置在各种免疫计画中有哪些新兴应用？

由于需要更有效、更方便、更安全的疫苗接种方法，疫苗输送装置在各种疫苗接种计画中的应用越来越广泛。在常规儿童免疫接种计划中，自动注射器和肌肉内注射器等设备通常用于注射麻疹、白喉和脊髓灰质炎等疾病的疫苗。这些设备确保准确和安全的管理，支持全球实现高免疫覆盖率和预防疫苗可预防疾病的努力。对于成人疫苗接种计划，包括流感、肺炎球菌和 COVID-19 疫苗接种，无针注射器和微针贴片正获得越来越广泛的支持，因为它们可以更快地进行注射、减轻疼痛并提高患者的依从性，尤其是对于有针头恐惧症的患者。

为了应对大流行和新兴感染疾病，快速、大规模的疫苗接种宣传活动需要多功能、可扩展的接种解决方案。在新冠肺炎疫情期间，为了有效接种疫苗，人们引入了各种各样的给药装置，从用于肌肉注射疫苗的自动拆卸注射器到方便给药的鼻腔喷雾剂。 mRNA 疫苗的开发需要专门的递送技术来保持稳定性和有效性，这也推动了专门注射器和低温运输相容设备的采用。狂犬病和结核病等疫苗的皮内注射器的使用越来越广泛，凸显了对能够采用剂量节约策略的设备的需求日益增长，以便在资源有限的环境中最大限度地增加疫苗供应。

癌症疫苗和治疗爱滋病毒和肝炎等慢性疾病的疫苗也受益于允许有针对性给药的创新输送装置。例如，在一段可控的时间内透过皮下注射治疗性疫苗的可穿戴注射器已成为癌症免疫疗法中一种很有前途的解决方案。疫苗接种装置的多功能性和适应性在这些不同的免疫计划中发挥关键作用，以实现有效的疫苗接种覆盖率，改善患者治疗结果并支持全球卫生倡议。

推动疫苗输送装置市场成长的因素是什么？

疫苗输送装置市场的成长受到多种因素的推动，包括全球疫苗接种活动的增加、疫苗研发的进步以及对更安全、更有效的输送方法的需求。主要成长要素之一将是由于常规免疫计划、大流行病防范和应对新兴感染疾病而对疫苗的需求不断增加。随着各国政府和国际组织致力于提高疫苗接种覆盖率和接种率，对可靠、扩充性的输送设备的需求正在激增。微针贴片、自毁注射器和无针注射器等技术创新减轻了传统针头接种方法带来的后勤挑战，并有助于大规模疫苗宣传活动。

COVID-19 疫苗的快速开发和部署凸显了对先进给药装置的需求，以实现更快的给药和安全有效的免疫。 mRNA、DNA 和病毒载体疫苗的扩展通常需要专门的递送技术，这推动了对维持疫苗稳定性和优化免疫反应的创新设备的进一步需求。人们越来越关注无针、微创给药方法，以提高患者的依从性并降低针头相关风险，这正在加速已开发地区和发展中地区对新型给药技术的采用。

政府倡议、医疗改革和扩大疫苗接种计划也促进了市场成长。例如，世界卫生组织（WHO）和联合国儿童基金会强调使用安全注射技术，并提倡采用自毁注射器和其他安全设计的设备，以防止交叉污染并提高疫苗安全性。此外，居家医疗和分散医疗保健的兴起将推动对自我管理疫苗设备（如微针贴片和滴鼻剂）的需求，从而支持更灵活的疫苗接种策略。随着设备技术、数位整合和永续製造的不断创新，在全球努力使疫苗更易于取得、更安全和更有效的推动下，疫苗输送设备市场有望实现强劲成长。

部分

装置（注射器、喷射注射器、其他装置）；给药途径（肌肉注射、皮下注射、皮内注射、其他给药途径）

受访公司范例（总合42家公司）

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc.（Inovio Pharmaceuticals, Inc.）
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP23010

Global Vaccine Delivery Devices Market to Reach US$6.6 Billion by 2030

The global market for Vaccine Delivery Devices estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Jet Injectors segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.5% CAGR

The Vaccine Delivery Devices market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vaccine Delivery Devices Market - Key Trends & Drivers Summarized

What Are Vaccine Delivery Devices, and Why Are They So Crucial in Modern Immunization?

Vaccine Delivery Devices are specialized tools and technologies designed to administer vaccines safely, effectively, and accurately. These devices include syringes, needle-free injectors, microneedle patches, nasal sprays, intradermal injectors, and oral delivery devices. They are used to deliver various types of vaccines, including inactivated, live-attenuated, mRNA, subunit, and viral vector vaccines, ensuring the vaccines reach the appropriate tissue for optimal immune response. These devices not only improve the efficiency and accuracy of vaccine administration but also enhance patient compliance, reduce the risk of needle-stick injuries, and minimize wastage.

The importance of vaccine delivery devices lies in their ability to support successful immunization programs by ensuring safe and effective vaccine administration. Efficient vaccine delivery is critical for achieving high immunization coverage, especially in mass vaccination campaigns and public health initiatives aimed at controlling infectious diseases. Devices like auto-disable syringes help prevent reuse and reduce infection risks, while needle-free injectors improve vaccine acceptance among needle-phobic populations. As global vaccination needs grow, particularly in response to pandemics, routine immunization, and emerging infectious diseases, vaccine delivery devices have become essential components of healthcare infrastructure, supporting timely and effective immunization efforts.

How Are Technological Advancements Shaping the Vaccine Delivery Devices Market?

Technological advancements have significantly improved the design, safety, and efficiency of Vaccine Delivery Devices, driving innovation across immunization programs worldwide. One of the major developments is the introduction of microneedle patches, which offer a painless, minimally invasive way to deliver vaccines intradermally. Microneedle patches are coated or filled with vaccines and can be self-administered, making them ideal for mass vaccination campaigns, remote locations, and low-resource settings. These patches do not require refrigeration, reducing cold chain logistics and facilitating broader access to vaccines, especially in developing countries.

Another key advancement is in the development of needle-free injectors, which use high-pressure streams to deliver vaccines through the skin without the use of needles. These devices reduce the risk of needle-stick injuries, improve patient compliance, and minimize biohazard waste. Needle-free injectors have been used in administering vaccines for diseases like influenza, measles, and hepatitis, and are being adapted for emerging vaccines, including those for COVID-19 and tuberculosis. In addition to needle-free systems, innovations in auto-disable syringes have improved safety during immunization. These syringes are designed to lock automatically after a single use, preventing reuse and reducing the risk of cross-contamination, making them crucial for safe vaccine administration, especially in mass campaigns.

The rise of smart delivery devices that integrate digital technology is transforming the market as well. Smart syringes and wearable injectors can monitor dosing accuracy, track administration, and collect real-time data on vaccination coverage, helping healthcare providers improve immunization programs and vaccine tracking. Advances in intranasal delivery systems have also expanded the options for non-invasive vaccine administration, offering easy and efficient delivery of vaccines such as the flu vaccine. These technological innovations are not only improving the performance and safety of vaccine delivery devices but also aligning with global goals for more accessible, user-friendly, and sustainable immunization solutions.

What Are the Emerging Applications of Vaccine Delivery Devices Across Different Immunization Programs?

Vaccine Delivery Devices are finding expanding applications across a wide range of immunization programs, driven by the need for more efficient, accessible, and safer vaccination methods. In routine childhood immunization programs, devices like auto-disable syringes and intramuscular injectors are commonly used to deliver vaccines for diseases such as measles, diphtheria, and polio. These devices ensure precise dosing and safe administration, supporting global efforts to achieve high immunization coverage and prevent vaccine-preventable diseases. In adult immunization programs, including influenza, pneumococcal, and COVID-19 vaccinations, needle-free injectors and microneedle patches are gaining traction as they offer faster administration, reduced pain, and improved patient compliance, particularly among needle-phobic individuals.

In response to pandemics and emerging infectious diseases, rapid and large-scale vaccination campaigns require versatile and scalable delivery solutions. During the COVID-19 pandemic, a variety of delivery devices were deployed to ensure efficient vaccine rollout, from auto-disable syringes for intramuscular vaccines to intranasal sprays for easier administration. The development of mRNA vaccines, which require specific delivery techniques to maintain stability and efficacy, has also driven the adoption of specialized injectors and cold-chain-compatible devices. The expanding use of intradermal injectors for vaccines like rabies and tuberculosis highlights the growing demand for devices that allow for dose-sparing strategies, maximizing vaccine supply in resource-limited settings.

Therapeutic vaccines, such as cancer vaccines and those for chronic diseases like HIV and hepatitis, also benefit from innovative delivery devices that provide targeted administration. For example, wearable injectors that deliver therapeutic vaccines subcutaneously over a controlled period have emerged as a promising solution in cancer immunotherapy. The versatility and adaptability of vaccine delivery devices across these diverse immunization programs reflect their critical role in achieving effective vaccination coverage, improving patient outcomes, and supporting global health initiatives.

What Drives Growth in the Vaccine Delivery Devices Market?

The growth in the Vaccine Delivery Devices market is driven by several factors, including increasing global immunization efforts, advancements in vaccine development, and the need for safer and more efficient delivery methods. One of the primary growth drivers is the rising demand for vaccines, fueled by routine immunization programs, pandemic preparedness, and efforts to address emerging infectious diseases. As governments and international organizations focus on improving vaccination rates and coverage, the demand for reliable, scalable delivery devices has surged. Innovations such as microneedle patches, auto-disable syringes, and needle-free injectors have supported mass vaccination campaigns, reducing the logistical challenges associated with traditional needle-based methods.

The rapid development and deployment of COVID-19 vaccines highlighted the critical need for advanced delivery devices that can facilitate faster administration and ensure safe, effective immunization. The expansion of mRNA, DNA, and viral vector vaccines, which often require specialized delivery techniques, has further driven demand for innovative devices that maintain vaccine stability and optimize immune response. The increasing focus on needle-free and minimally invasive delivery methods, which improve patient compliance and reduce needle-associated risks, has accelerated the adoption of new delivery technologies in both developed and developing regions.

Government initiatives, healthcare reforms, and expanded vaccine access programs have also contributed to market growth. For example, the World Health Organization (WHO) and UNICEF have emphasized the use of safe injection practices, promoting the adoption of auto-disable syringes and other safety-engineered devices to prevent cross-contamination and improve vaccine safety. Additionally, the rise of home-based and decentralized healthcare services has increased demand for self-administrable vaccine devices, such as microneedle patches and nasal sprays, supporting more flexible vaccination strategies. With ongoing innovations in device technology, digital integration, and sustainable manufacturing, the Vaccine Delivery Devices market is poised for robust growth, driven by global efforts to enhance vaccine accessibility, safety, and efficiency.

SCOPE OF STUDY:

The report analyzes the Vaccine Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Syringes, Jet Injectors, Other Devices); Route of Administration (Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination, Other Route of Administrations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc. (Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vaccine Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Vaccine Administration Drives Demand for Vaccine Delivery Devices
    • Advancements in Needle-Free Injection Systems Propel Vaccine Delivery Device Market
    • Expanding Role of Self-Administered Vaccines Sets the Stage for Device Adoption
    • Case Overview: Demand for Single-Use Syringes Enhances Vaccine Delivery Device Market
    • Innovations in Microneedle Technology Generate New Opportunities for Vaccine Devices
    • Focus on Reducing Vaccine Wastage Bodes Well for Delivery Device Adoption
    • Growing Use of Auto-Disable Syringes Sustains Vaccine Delivery Device Market
    • Expanding Role of Prefilled Syringes Enhances Vaccine Delivery Market Growth
    • Push for Improved Immunization Programs Drives Vaccine Delivery Device Adoption
    • Case Overview: Innovations in Smart Syringes Propel Vaccine Delivery Devices
    • Innovations in Intradermal Delivery Propel Vaccine Delivery Device Growth
    • Focus on Mass Immunization Programs Bodes Well for Vaccine Delivery Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intramuscular Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Subcutaneous Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intradermal Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • JAPAN
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CHINA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • EUROPE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • FRANCE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • GERMANY
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • INDIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AFRICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030

IV. COMPETITION